03 NPHLA Intelligence desk
For med spas, aesthetic practices, prescribers and pharmacies: new clearances, approvals, safety warnings and research — with every item labelled for what it is: approved, cleared, off-label, investigational or simply a marketing claim.
Featured on this desk
Every new official record on the Aesthetics, Regenerative & Longevity Medicine desk since this morning, each linked to its primary source.
NPHLA tracked 11 new official records on this desk today: 4 trial updates, 6 new studies, 1 FDA announcement.
Automated from official records13 sources1 min read
Nothing in this view yet. New briefings appear as the desk publishes them.
Not applicable, Assiut University. Conditions: Androgenetic Alopecia; Cicatricial Alopecia. Interventions: Integrated Evidence-Based FUE Protocol; Standard FUE Practice. Investigational: trial-stage therapies are not approved for the use studied.
Not applicable, Cellese Inc.. Conditions: Skin Aging; Skin Quality. Interventions: Mechanical microneedling; AnteAGE Exosomes and PEARL Multiplier; AnteAGE Homecare Regimen. Investigational: trial-stage therapies are not approved for the use studied.
Not applicable, Cellese Inc.. Conditions: Skin Aging; Facial Rhytides; Skin Tone. Interventions: AnteAGE Biosome Treatment Solution; Radiofrequency Microneedling; AnteAGE Homecare Regimen. Investigational: trial-stage therapies are not approved for the use studied.
The U.S. Attorney’s Office for the Middle District of Florida and the Criminal Division of the U.S. Department of Justice today announced federal charges against Swapnadip Roy, 33, and Vicky Ramancha, 37, both Indian nationals.
